idiopathic parkinson's disease
Showing 1 - 25 of 64
Idiopathic Parkinson's Disease Trial in Shanghai (hAESCs)
Not yet recruiting
- Idiopathic Parkinson's Disease
- hAESCs
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Jan 28, 2023
Fatigue, Sleep and Quality of Life in Parkinson's Patients
Recruiting
- Idiopathic Parkinson's Disease
-
Niğde, TurkeyNigde Omer Halisdemir University Treaning and Research Hospital
Jan 18, 2023
Balance, Activity-specific Balance Confidence and Quality of
Recruiting
- Idiopathic Parkinson's Disease
- Assessment
-
Niğde, TurkeyNigde Omer Halisdemir University Treaning and Research Hospital
Jan 8, 2023
Idiopathic Parkinson's Disease Trial in United States (CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]), Sham
Completed
- Idiopathic Parkinson's Disease
- CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN])
- Sham Surgery
-
Birmingham, Alabama
- +8 more
Nov 8, 2022
HRQoL in Parkinson's Disease Patients Patients: Role of Social
Completed
- Parkinson Disease
- +5 more
-
Columbus, OhioThe Ohio State University
Oct 10, 2022
Idiopathic Parkinson's Disease, Progressive Supranuclear Palsy Trial in Cassino (FR), Rome (Foot Mechanical Stimulation
Terminated
- Idiopathic Parkinson's Disease
- Progressive Supranuclear Palsy
- Foot Mechanical Stimulation (GONDOLA)
-
Cassino, FR, Italy
- +2 more
Sep 30, 2022
Idiopathic Parkinson's Disease Trial in Pozzilli (PD patients H&Y=1.5-2 Medications ON, PD patients H&Y=1.5-2 Medications OFF,
Recruiting
- Idiopathic Parkinson's Disease
- PD patients H&Y=1.5-2 Medications ON
- +4 more
-
Pozzilli, Isernia, ItalyIRCSS Neuromed Hospital
May 18, 2022
Idiopathic Parkinson's Disease, Parkinson Disease, Depression Trial in Baltimore (Transcranial Direct Current Stimulation)
Recruiting
- Idiopathic Parkinson's Disease
- +2 more
- Transcranial Direct Current Stimulation
-
Baltimore, MarylandJohns Hopkins Hospital / Johns Hopkins University
Mar 28, 2022
Idiopathic Parkinson's Disease, Parkinson's Disease, Basal Ganglia Disease Trial in United States (VY-AADC01)
Completed
- Idiopathic Parkinson's Disease
- +8 more
-
San Francisco, California
- +3 more
Mar 17, 2022
Gait, Foot Pressure Distribution and Balance in Parkinson's
Completed
- Idiopathic Parkinson's Disease
-
Ankara, TurkeyHacettepe University
Feb 20, 2022
Idiopathic Parkinson's Disease Trial (Aadipose-Derived Mesenchymal Stem Cells)
Not yet recruiting
- Idiopathic Parkinson's Disease
- Aadipose-Derived Mesenchymal Stem Cells
- (no location specified)
Jan 20, 2022
Idiopathic Parkinson's Disease Trial in Ankara (control group, mobilization group)
Completed
- Idiopathic Parkinson's Disease
- control group
- mobilization group
-
Ankara, TurkeyHacettepe University
Oct 14, 2021
Idiopathic Parkinson's Disease Trial in Ankara (cervical mobilization, control)
Completed
- Idiopathic Parkinson's Disease
- cervical mobilization
- control
-
Ankara, TurkeyHacettepe University
Oct 14, 2021
Idiopathic Parkinson's Disease Trial in United States (apomorphine infusion)
Unknown status
- Idiopathic Parkinson's Disease
- apomorphine infusion
-
Phoenix, Arizona
- +17 more
Nov 25, 2020
Idiopathic Parkinson's Disease Trial in Worldwide (Istradefylline 40 mg, Istradefylline 20 mg, Placebo)
Completed
- Idiopathic Parkinson's Disease
- Istradefylline 40 mg
- +2 more
-
Phoenix, Arizona
- +88 more
Oct 28, 2020
Idiopathic Parkinson's Disease Trial in Worldwide (Deep Brain Stimulation)
Completed
- Idiopathic Parkinson's Disease
- Deep Brain Stimulation
-
Vienna, Austria
- +6 more
Nov 17, 2020
Idiopathic Parkinson's Disease Trial in United States (CERE-120: Adeno-Associated Virus Delivery of Neurturin, Sham Surgery)
Completed
- Idiopathic Parkinson's Disease
- CERE-120: Adeno-Associated Virus Delivery of Neurturin
- Sham Surgery
-
Birmingham, Alabama
- +10 more
Apr 7, 2020
Idiopathic Parkinson's Disease Trial in Worldwide (Istradefylline 20 mg or 40 mg)
Completed
- Idiopathic Parkinson's Disease
- Istradefylline 20 mg or 40 mg
-
Phoenix, Arizona
- +54 more
Jan 9, 2020
Idiopathic Parkinson's Disease Trial in Bingham Farms, Portland (IPX054 200 mg, IPX054 250 mg, CD-LD IR)
Completed
- Idiopathic Parkinson's Disease
- IPX054 200 mg
- +7 more
-
Bingham Farms, Michigan
- +1 more
Oct 25, 2019
Idiopathic Parkinson's Disease Trial in Sunnyvale, Lawrence (IPX054 100 mg, IPX054 150 mg, IPX054 200 mg)
Completed
- Idiopathic Parkinson's Disease
- IPX054 100 mg
- +4 more
-
Sunnyvale, California
- +1 more
Oct 25, 2019
Idiopathic Parkinson's Disease Trial in Worldwide (CVT-301)
Completed
- Idiopathic Parkinson's Disease
-
Scottsdale, Arizona
- +73 more
Jul 30, 2019
Idiopathic Parkinson's Disease Trial in Worldwide (CVT-301 Low Dose, CVT-301 High Dose, Placebo)
Completed
- Idiopathic Parkinson's Disease
- CVT-301 Low Dose
- +2 more
-
Scottsdale, Arizona
- +73 more
May 23, 2019
Idiopathic Parkinson's Disease Trial in Worldwide (CVT-301, Observational cohort)
Completed
- Idiopathic Parkinson's Disease
- CVT-301
- Observational cohort
-
Scottsdale, Arizona
- +75 more
May 23, 2019
Idiopathic Parkinson's Disease, Drug Induced Dyskinesia Trial in United States (Topiramate, Placebo, Amantadine)
Terminated
- Idiopathic Parkinson's Disease
- Drug Induced Dyskinesia
- Topiramate
- +2 more
-
Birmingham, Alabama
- +4 more
Mar 25, 2019
Idiopathic Parkinson's Disease Trial in Worldwide (tozadenant, )
Terminated
- Idiopathic Parkinson's Disease
- tozadenant
- placebo
-
Birmingham, Alabama
- +70 more
Mar 25, 2019